Page last updated: 2024-11-04

vorinostat and Hemorrhage, Subarachnoid

vorinostat has been researched along with Hemorrhage, Subarachnoid in 2 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Luo, K1
Wang, Z1
Zhuang, K1
Yuan, S1
Liu, F1
Liu, A1
Lu, J1
Huang, X1
Deng, A1
Yao, H1
Wu, G1
Wang, N1
Gui, H1
Ren, M1
Guo, S1

Other Studies

2 other studies available for vorinostat and Hemorrhage, Subarachnoid

ArticleYear
Suberoylanilide hydroxamic acid suppresses axonal damage and neurological dysfunction after subarachnoid hemorrhage via the HDAC1/HSP70/TDP-43 axis.
    Experimental & molecular medicine, 2022, Volume: 54, Issue:9

    Topics: Animals; Apoptosis; DNA-Binding Proteins; Histone Deacetylase 1; Histone Deacetylase Inhibitors; HSP

2022
miR-452-3p Targets HDAC3 to Inhibit p65 Deacetylation and Activate the NF-κB Signaling Pathway in Early Brain Injury after Subarachnoid Hemorrhage.
    Neurocritical care, 2022, Volume: 37, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Brain Injuries; Histone Deacetylases; Lactate Dehydrog

2022